home





























 

















 





















hrsa

participating institutions:
Johns Hopkins University AIDS Service, New York State DOH AIDS Institute, The CORE Center, Cook County Hospital



NEWS AND NEW DEVELOPMENTS



Resistance study to re-evaluate HAART [Kenyon G. Nat Medicine 2001; 7: 515]:This report announces the anticipated launch of Optima in June 2001. This is a $15.3 million study entitled "Options in Management with Antiretrovirals Study" and will be the first study done by the Tri-National Clinical Trials Research Institute which represents a collaboration between the Canadian Institutes of Health Research, the VA in the United States, and the Medical Research Council in the United Kingdom. Over 3 years, the trial will include an estimated 1,700 patients at 70 sites, including 22 hospitals in Canada, 25 in the U.K. and 30 VA hospitals in the U.S. The initial study will examine relative benefit of five versus three antiretroviral agents after STI with the choice of agents left to physician decision.
posted 6/20/2001





Copyright © 2001-2002. The National AIDS Education and Training Centers Program on behalf of its AETC National Resource Center. All rights reserved.

Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.